CSL Ltd (CSLLY)
89.60
-0.56
(-0.62%)
USD |
OTCM |
Apr 26, 16:00
CSL Cash from Financing (TTM): -1.644B for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -1.644B |
June 30, 2023 | 456.00M |
December 31, 2022 | 5.296B |
June 30, 2022 | 7.676B |
December 31, 2021 | 2.778B |
June 30, 2021 | -1.402B |
December 31, 2020 | -602.70M |
June 30, 2020 | -642.70M |
December 31, 2019 | -898.60M |
June 30, 2019 | -491.50M |
December 31, 2018 | -534.70M |
June 30, 2018 | -371.50M |
December 31, 2017 | -121.60M |
June 30, 2017 | -103.50M |
December 31, 2016 | -672.70M |
June 30, 2016 | -362.40M |
December 31, 2015 | -571.20M |
June 30, 2015 | -828.10M |
December 31, 2014 | -663.00M |
June 30, 2014 | -1.137B |
December 31, 2013 | -736.50M |
June 30, 2013 | -1.218B |
December 31, 2012 | -1.508B |
June 30, 2012 | -217.37M |
December 31, 2011 | -390.66M |
Date | Value |
---|---|
June 30, 2011 | -1.377B |
December 31, 2010 | -869.13M |
June 30, 2010 | -1.999B |
December 31, 2009 | -1.690B |
June 30, 2009 | 850.73M |
December 31, 2008 | 717.00M |
June 30, 2008 | -240.32M |
December 31, 2007 | 97.03M |
June 30, 2007 | 87.00M |
December 31, 2006 | -134.28M |
June 30, 2006 | -264.39M |
December 31, 2005 | -459.91M |
June 30, 2005 | -127.10M |
December 31, 2004 | 141.22M |
June 30, 2004 | 378.94M |
December 31, 2003 | 312.37M |
June 30, 2003 | 26.47M |
December 31, 2002 | 38.96M |
June 30, 2002 | 141.78M |
December 31, 2001 | 105.52M |
June 30, 2001 | 271.74M |
December 31, 2000 | 506.76M |
June 30, 2000 | 192.53M |
December 31, 1999 | -21.92M |
June 30, 1999 | -20.08M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-1.644B
Minimum
Dec 2023
7.676B
Maximum
Jun 2022
1.052B
Average
-547.10M
Median
Cash from Financing (TTM) Benchmarks
Alterity Therapeutics Ltd | 33.78M |
Kazia Therapeutics Ltd | 8.600M |
Immutep Ltd | 13.70M |
Opthea Ltd | 138.48M |
Mesoblast Ltd | 74.50M |